Blog
The Super Bowl Catalyst: Why DraftKings Could Snap Back Fast
Investing in the gaming sector often requires a strong stomach, not just for the regulatory headlines, but for the games themselves. Recently, DraftKings (NASDAQ: DKNG) stock has experienced some
The One Metric Bulls Watch in Palantir Before Earnings
When many investors talk about Palantir Technologies Inc. (NASDAQ: PLTR), they’ll point to a price-to-earnings (P/E) ratio of over 550x and a price-to-sales (P/S) ratio that is over 142x. These
Small Cap Spike: Semi Stock AEHR Up +40% in 2026 Post-Earnings
For shares of Aehr Test Systems (NASDAQ: AEHR), it's hard to imagine a hotter start to 2026. As of the Jan. 20 close, the stock is already up 44% on the year.
The most recent earnings release on
Tupperware Lives On: Why Betterware Is Up 8% on the News
Investors hate uncertainty, but they love a bargain. In the third week of January 2026, Betterware de Mexico (NYSE: BWMX) gave the market exactly what it wanted. Shares of the company surged by
Made in the USA: Stardust Power’s 18% Breakout
Wall Street has turned its attention to the domestic industrial sector this January, driving shares of Stardust Power (NASDAQ: SDST) up over 18% in the past 30 days. The surge in price and trading
ICE vs Coinbase: The Race for Dominance in a 24/7 Market
The opening bell of the New York Stock Exchange is an iconic symbol of global finance. However, for a new generation of investors, market hours are an outdated concept. The distinction between
Fifth Third Bancorp: An Inflection With Double-Digit Upside Ahead
Fifth Third Bancorp (NASDAQ: FITB) stock is at an inflection point, and double-digit upside could lie ahead. The combination of favorable economic conditions, resilient consumer markets
The Nuts and Bolts of Fastenal Earnings—And What Comes Next
Fastenal’s (NASDAQ: FAST) second half of 2025 was impacted by macroeconomic headwinds and a downshift in analyst sentiment, which, while painful for investors, has now left its stock price in the
D.R. Horton Stock Tests Support Following Earnings Report
Shares of homebuilder D.R. Horton Inc. (NYSE: DHI) are down about 1% in mid-day trading after the company reported its earnings for the first quarter of its 2026 fiscal year. This came despite
Riot Platforms: A $311M AMD Deal Changes the HPC Game
In mid-January, the financial markets witnessed a notable anomaly. While Bitcoin's ($BTC) price faced significant downward pressure, dropping toward $91,000 due to rising geopolitical tensions
Tesla Bulls vs. Bears Are Getting Loud Ahead of Earnings
Shares of Tesla Inc (NASDAQ: TSLA) are trading around $425 as we head into next week’s earnings report, down roughly 15% from the all-time high set in December.
That pullback has been
Defense Spending Is Rising—Here Are 3 Stocks Built for Turbulent Times
We’re only three weeks into 2026, but it already feels like Billy Joel can add another verse to We Didn’t Start the Fire:
Ukraine/Russia tensions boil,
U.S. wants Caracas oil.
Massive protests
3M Earnings: Fundamentals and Capital Returns to Drive Highs in 2026
3M’s (NYSE: MMM) Q4 2025 results and 2026 guidance update failed to trigger a rally; however, they align with a long-term outlook for quality and capital returns that has this market on track to
2 Ways to Trade Amazon Ahead of Earnings
Shares of tech giant Amazon.com Inc. (NASDAQ: AMZN) have been trading just above $230 the week of Jan. 20 as the company gears up for its first earnings report of the year, due in early February
Sea, Space, & Sky: 3 Frontier Robotics Stocks Under $20
For investors in the technology sector, factory automation has long been a standard trade. For years, investors have flocked to companies that build robots to move boxes in warehouses or weld
Rocket Lab Gets a Big Upgrade: Will Upside Follow?
Shares of Rocket Lab (NASDAQ: RKLB) received another major vote of confidence this month after financial heavyweight Morgan Stanley significantly upgraded both its rating and price target on the
Moderna Pops 17%—Is There Life in MRNA, Down 90% from COVID High?
In a blast from the past, COVID-19 vaccine developer Moderna (NASDAQ: MRNA) just made headlines in 2026. Shares jumped up more than 17% on Jan. 13, Moderna's largest single-day up-move in over
AMD Rebound Begins: It’s Not Too Late to Get In
Advanced Micro Devices' (NASDAQ: AMD) late 2025 sell-off hit and confirmed its bottom in early 2026, indicating a robust rebound could lie ahead.
The 15% gain posted in the second week of 2026
Utility Gas Inflation Is Soaring. This Stock Is a Clear Winner
On Jan. 13, the U.S. Bureau of Labor Statistics released December’s Consumer Price Index data, showing that headline inflation rose at a year-over-year (YOY) pace of 2.7%.
While there were some
Unity Software Is Falling—So Why Are Pros Getting More Bullish?
Unity Software (NYSE: U) experienced a jarring sell-off in mid-January 2026. The stock tumbled nearly 7% to close around $40.96, capping off its difficult start to 2026. For an investor looking
AI Needs Power Now—Bloom Energy and American Electric Power Deliver
Investors in the energy sector have spent the last five years waiting for the hydrogen economy to arrive. For a long time, the narrative was driven by government subsidies, environmental pledges
2 Healthcare Names That Could Get a Big Boost From Earnings
Active traders expect companies in the healthcare sector to experience significant share price spikes tied to milestones in the development of new therapies and medical products. The volatility in
3 Key Ways D-Wave Is Developing an Advantage in Quantum Computing
D-Wave Quantum Inc. (NYSE: QBTS), the $10-billion quantum computing company with a share price that has soared by more than 358% in the last 12 months, is working to position itself as the go-to
Short Squeeze Season: Is Super Micro Ready to Fly?
In the middle of January 2026 the stock market witnessed a shift in momentum for one of its most controversial companies. Shares of Super Micro Computer (NASDAQ: SMCI) jumped nearly 11%, closing
3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026
The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries higher-than-average risk. The success of these companies depends on clinical

